MFDS — authorised 24 September 1996
- Marketing authorisation holder: FRESENIUS KABI USA
- Status: likely_approved
🇰🇷 Naropin in South Korea
MFDS authorised Naropin on 24 September 1996
Marketing authorisation
Naropin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in South Korea
Frequently asked questions
Is Naropin approved in South Korea?
Yes. MFDS authorised it on 24 September 1996.
Who is the marketing authorisation holder for Naropin in South Korea?
FRESENIUS KABI USA holds the South Korean marketing authorisation.